[HTML][HTML] Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
Purpose The purpose of this study was to determine if somatic mutations are associated with
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - Radiation …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The purpose of this study was to determine if somatic mutations are associated with
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - Radiation Oncology …, 2021 - search.ebscohost.com
Purpose: The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
[PDF][PDF] Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding, A Hacker-Prietz… - 2021 - academia.edu
Purpose: The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - Radiation …, 2021 - oldkmbase.medric.or.kr
Purpose: The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - 대한방사선종양 …, 2021 - scholar.kyobobook.co.kr
Purpose: The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - Radiation Oncology … - KoreaMed
Purpose The purpose of this study was to determine if somatic mutations are associated with
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV REDDY, CS HILL, S SEHGAL… - Radiation Oncology …, 2021 - pesquisa.bvsalud.org
Purpose@# The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
[PDF][PDF] Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding, A Hacker-Prietz… - 2021 - pdfs.semanticscholar.org
Purpose: The purpose of this study was to determine if somatic mutations are associated
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
with clinical and pathologic outcomes in patients with borderline resectable pancreatic …
[HTML][HTML] Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant …
AV Reddy, CS Hill, S Sehgal, D Ding… - Radiation Oncology …, 2021 - e-roj.org
Purpose The purpose of this study was to determine if somatic mutations are associated with
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …
clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer …